Thu, 12 Oct 2023 12:30:05 GMT
Dialysis provider shares plummet
The stock prices of firms that provide dialysis services to diabetes and kidney failure patients have dropped due to Novo Nordisk revealing that Ozempic has shown success in permanently treating these diseases.